肠道菌群宏基因组联合代谢与深度免疫分析在慢性肾脏病中的研究
该研究对慢性肾脏病患者及非慢性肾脏病对照进行肠道菌群宏基因组、靶向血清代谢组和深度免疫分型等多组学分析,发现慢性肾脏病患者肠道菌群功能中碳水化合物活性酶基因多样性及丰度降低,而抗生素耐药、氮循环酶及毒力因子基因丰度增加;基于血清代谢物或免疫特征的模型可预测肾功能损伤,但基于肠道菌群功能谱(尤其是CAZyme基因)的模型预测早期疾病性能更优;共现分析揭示了慢性肾脏病中宿主-微生物的协调关系。
要点
- 慢性肾脏病患者肠道菌群CAZyme基因多样性及丰度降低。
- 慢性肾脏病患者肠道菌群抗生素耐药、氮循环酶及毒力因子基因丰度增加。
- 基于肠道菌群功能谱(尤其是CAZyme基因)的模型预测早期慢性肾脏病性能优于血清代谢物或免疫特征模型。
核心结论
- 多组学整合揭示慢性肾脏病中肠道菌群系统水平特征与宿主-微生物共代谢物及肾功能稳健相关,可能具有病因学和诊断意义。
研究设计与样本
- 在慢性肾脏病患者和非慢性肾脏病对照队列中开展多组学测量,包括系统级肠道菌群宏基因组、靶向血清代谢组和深度免疫分型。
主要发现
- 慢性肾脏病患者肠道菌群功能谱中碳水化合物活性酶(CAZyme)基因多样性和丰度降低,抗生素耐药、氮循环酶和毒力因子基因丰度增加。
- 基于血清代谢物(氨基酸、胆汁酸和短链脂肪酸)或免疫分型的模型可预测肾功能损伤,但预测性能不及许多肠道菌群功能谱模型,其中CAZyme基因模型预测早期疾病性能最佳。
- 共现分析显示慢性肾脏病中宿主-微生物协调关系,肠道菌群多个分类和功能谱与循环代谢物显著相关比例最高,免疫特征与微生物编码代谢通路丰度及血清氨基酸水平(如B细胞簇色氨酸和B细胞簇色氨酸代谢)中度相关。
临床怎么用
- 肠道菌群功能谱(尤其是CAZyme基因)或可作为慢性肾脏病早期预测的潜在生物标志物,但需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Perturbation of gut microbiota has been linked to chronic kidney disease (CKD), which was correlated with a sophisticated milieu of metabolic and immune dysregulation. METHODS: To clarify the underlying host-microbe interaction in CKD, we performed multi-omics measurements, including systems-level gut microbiome, targeted serum metabolome and deep immunotyping, in a cohort of patients and non-CKD controls. RESULTS: Our analyses on functional profiles of the gut microbiome showed a decrease in the diversity and abundance of carbohydrate-active enzyme (CAZyme) genes but an increase in the abundance of antibiotic resistance, nitrogen cycling enzyme and virulence factor genes in CKD. Moreover, models generated using measurements of serum metabolites (amino acids, bile acids and short-chain fatty acids) or immunotypes were predictive of renal impairment but less so than many of the functional profiles derived from gut microbiota, with the CAZyme genes being the top-performing model to accurately predict the early stage of diseases. In addition, co-occurrence analyses revealed coordinated host-microbe relationships in CKD. Specifically, the highest fractions of significant correlations were identified with circulating metabolites by several taxonomic and functional profiles of gut microbiome, while immunotype features were moderately associated with the abundance of microbiome-encoded metabolic pathways and serum levels of amino acids (e.g. B cell cluster tryptophan and B cell cluster tryptophan metabolism). CONCLUSION: Overall, our multi-omics integration revealed several signatures of systems-level gut microbiome in robust associations with host-microbe co-metabolites and renal function, which may have aetiological and diagnostic implications in CKD.
引用
- Wu IW, Chang LC, Wu YL, et al. Gut flora metagenomic analysis coupled with metabolic and deep immune profiling in chronic kidney disease. Nephrol Dial Transplant. 2024. PMID: 38244232. doi:10.1093/ndt/gfae013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。